Biologics and Novel Therapeutics in Food Allergy.
Where this comes from
- Record sourced from PubMed, PMID 41956612.
- Also identified by DOI 10.1016/j.jaip.2026.01.044.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The US Food and Drug Administration approval of omalizumab for the treatment of food allergy has opened the door for therapeutics targeting the underlying mechanisms that drive food allergy. Here we discuss both approved and novel investigational therapeutic strategies targeting these allergic pathways for the treatment of food allergy.
Medical subject headings
- Food Hypersensitivity
- Anti-Allergic Agents
- Biological Products